The Resource Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults, prepared for Agency for Healthcare Research and Quality ; prepared by RTI-University of North Carolina Evidence-based Practice Center (EPC) ; investigators, Katrina E. Donahue [and others], (electronic resource)

Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults, prepared for Agency for Healthcare Research and Quality ; prepared by RTI-University of North Carolina Evidence-based Practice Center (EPC) ; investigators, Katrina E. Donahue [and others], (electronic resource)

Label
Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults
Title
Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults
Statement of responsibility
prepared for Agency for Healthcare Research and Quality ; prepared by RTI-University of North Carolina Evidence-based Practice Center (EPC) ; investigators, Katrina E. Donahue [and others]
Title variation
  • Drug therapy for rheumatoid arthritis and psoriatic arthritis in adults
  • Effective health care program
Contributor
Subject
Genre
Language
eng
Summary
"This report from the RTI-University of North Carolina Evidence-based Practice Center summarizes the evidence on the comparative efficacy, effectiveness, and harms of corticosteroids, synthetic DMARDs, and biologic DMARDs in the treatment of patients with either rheumatoid arthritis (RA) or psoriatic arthritis (PsA). The key questions (KQs) were developed through a public process in conjunction with the Scientific Resource Center at the Oregon Health and Science University. The KQs are as follows: KQ 1. For patients with rheumatoid arthritis or psoriatic arthritis, do drug therapies differ in their ability to reduce patient-reported symptoms, to slow or limit progression of radiographic joint damage, or to maintain remission? KQ 2. For patients with rheumatoid arthritis or psoriatic arthritis, do drug therapies differ in their ability to improve functional capacity or quality of life? KQ 3. For patients with rheumatoid arthritis or psoriatic arthritis, do drug therapies differ in harms, tolerability, adherence, or adverse effects? KQ 4. What are the comparative benefits and harms of drug therapies for rheumatoid arthritis and psoriatic arthritis in subgroups of patients based on stage of disease, history of prior therapy, demographics, concomitant therapies, or comorbidities?"--Publisher's description
Member of
Cataloging source
MMU
Funding information
Conducted by the RTI-University of North Carolina Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ)
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
WE 344
http://library.link/vocab/relatedWorkOrContributorName
  • Donahue, Katrina E
  • Research Triangle Institute-University of North Carolina Evidence-based Practice Center
  • United States
  • Effective Health Care Program (U.S.)
Series statement
  • Comparative effectiveness reviews
  • AHRQ publication,
Series volume
  • no. 11
  • no. 08-EHC004-EF
http://library.link/vocab/subjectName
  • Arthritis, Psoriatic
  • Arthritis, Rheumatoid
  • Antirheumatic Agents
  • Comparative Effectiveness Research
http://bibfra.me/vocab/relation/supportingbody
RzTDSdffmEM
Label
Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults, prepared for Agency for Healthcare Research and Quality ; prepared by RTI-University of North Carolina Evidence-based Practice Center (EPC) ; investigators, Katrina E. Donahue [and others], (electronic resource)
Instantiates
Publication
Note
  • Title from resource home page (NCBI Bookshelf, viewed August 15, 2011)
  • " November 2007"
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Control code
746799276
Dimensions
cm.
Extent
1 online resource (446 pages)
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations
Specific material designation
remote
System control number
(OCoLC)746799276
Label
Comparative effectiveness of drug therapy for rheumatoid arthritis and psoriatic arthritis in adults, prepared for Agency for Healthcare Research and Quality ; prepared by RTI-University of North Carolina Evidence-based Practice Center (EPC) ; investigators, Katrina E. Donahue [and others], (electronic resource)
Publication
Note
  • Title from resource home page (NCBI Bookshelf, viewed August 15, 2011)
  • " November 2007"
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Control code
746799276
Dimensions
cm.
Extent
1 online resource (446 pages)
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations
Specific material designation
remote
System control number
(OCoLC)746799276

Library Locations

  • St. Louis Mercantile LibraryBorrow it
    1 University Blvd, St. Louis, MO, 63121, US
    38.710138 -90.311107
  • Thomas Jefferson LibraryBorrow it
    1 University Blvd, St. Louis, MO, 63121, US
    38.710138 -90.311107
  • University ArchivesBorrow it
    703 Lewis Hall, Columbia, MO, 65211, US
  • University of Missouri-St. Louis Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
  • University of Missouri-St. Louis Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
  • Ward E Barnes Education LibraryBorrow it
    8001 Natural Bridge Rd, St. Louis, MO, 63121, US
    38.707079 -90.311355
Processing Feedback ...